Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular risks: new insights from Framingham.

D Levy1, W B Kannel

  • 1Cardiology Laboratory, Framingham Heart Study, MA 01701.

American Heart Journal
|July 1, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Rates of progression to hypertension among non-hypertensive subjects: implications for blood pressure screening.

European heart journal·2002
Same author

Genome scan for quantity of hand osteoarthritis: the Framingham Study.

Arthritis and rheumatism·2002
Same author

Risk factors in HIV-associated diarrhoeal disease: the role of drinking water, medication and immune status.

Epidemiology and infection·2002
Same author

Impact of high-normal blood pressure on the risk of cardiovascular disease.

The New England journal of medicine·2002
Same author

Distinct sensitizing effects of the cAMP-PKA second messenger cascade on rat dural mechanonociceptors.

The Journal of physiology·2002
Same author

Autologous endometrial coculture in patients with in vitro-fertilization (IVF) failure: correlations of outcome with leukemia inhibiting factor (LIF) production.

American journal of reproductive immunology (New York, N.Y. : 1989)·2002
Same journal

Stratified Medicine with Eplerenone for Myocardial Infarction or Injury and No obstructive Coronary Arteries: A Registry-Based Basket Trial.

American heart journal·2026
Same journal

Revised Lipid-Lowering Therapy Guidelines in a Nationally Representative Sample.

American heart journal·2026
Same journal

Cardiometabolic Health of Low- and Higher-Income Adults in the United States, 2009-2023.

American heart journal·2026
Same journal

Moving Beyond Technical Capability to Regulatory Integration for Digital Health Technology Devices-Brief Communication from the Cardiovascular Sciences Research Consortium.

American heart journal·2026
Same journal

THE SOCIETY OF CRITICAL CARE CARDIOLOGY - RATIONALE, BLUEPRINT, AND LESSONS LEARNED IN THE CREATION OF A NEW MULTIDISCIPLINARY PROFESSIONAL ORGANIZATION.

American heart journal·2026
Same journal

DOAC Score Among Patients Receiving Vitamin K Antagonists.

American heart journal·2026
See all related articles

Cardiovascular disease incidence has declined due to better management of risk factors like hypertension and high cholesterol. The Framingham Heart Study identified key risks, improving clinical understanding and reducing mortality.

Area of Science:

  • Cardiology
  • Public Health
  • Epidemiology

Background:

  • Cardiovascular disease is the leading cause of death in the US.
  • Incidence has decreased over the past 20 years.
  • Improved detection and management of risk factors are key drivers.

Purpose of the Study:

  • To highlight the impact of the Framingham Heart Study.
  • To identify major cardiovascular risk factors.
  • To inform strategies for reducing cardiovascular mortality.

Main Methods:

  • Longitudinal cohort study (Framingham Heart Study).
  • Follow-up of subjects since the late 1940s.
  • Analysis of risk factors including age, hypertension, smoking, cholesterol, diabetes, left ventricular hypertrophy, and obesity.

Related Experiment Videos

Main Results:

  • Identification of numerous cardiovascular risk factors.
  • Demonstration of the link between these factors and disease.
  • Understanding of modifiable risk factors.

Conclusions:

  • The Framingham Heart Study has significantly advanced cardiovascular risk factor understanding.
  • Improved management of identified risks has led to decreased incidence.
  • Continued research and clinical application are vital for further mortality reduction.